Харьковская Медицинская Академия Последипломного Образования
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківська Медична Академія Післядипломної Освіти, Харьковская Медицинская Академия Последипломного ОбразованияfiledCriticalХарківська Медична Академія Післядипломної Освіти
Priority to UA2001010192ApriorityCriticalpatent/UA39717A/en
Publication of UA39717ApublicationCriticalpatent/UA39717A/en
The method for the surgical treatment of the primary glaucoma provides for the meridian incisions through all the layers of the sclera. Three incisions in four meridians (positioned to 6, 12, 3, 9 hours) are made in parallel to the limb in the projection of sinus venosus of sclera. The depth of the incisions equals 2/3 of the depth of sclera. The length of the incisions is 4-5 mm.
UA2001010192A2001-01-102001-01-10Method for surgical treatment of primary glaucoma
UA39717A
(en)
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
Combined product, method for producing a part kit, part kit, method of treating a condition, use of a combined product or part kit, and a melagatran and an xa factor inhibitor, or of a pharmaceutically acceptable derivative thereof
Combined product, method for producing a part kit, part kit, method of treating a condition, use of a combined product or part kit, and a melagatran and a factor viia inhibitor, or of a pharmaceutically acceptable derivative thereof
Combined product, method of producing the same, kit of parts, method of treating a condition, uses of a product or kit of melagatran or a pharmaceutically acceptable derivative thereof, together with dexamethasone or a pharmaceutically acceptable derivative thereof of the same